LON:BTEC Holdings Information

LON:BTEC is an equity ETF with a total of 266 individual holdings. The top holdings are Amgen stock at 7.31%, Gilead Sciences at 7.21%, Vertex Pharmaceuticals at 7.14%, Regeneron Pharmaceuticals at 6.25%, and Alnylam Pharmaceuticals at 3.24%.

Total Holdings

266

Top 10 Percentage

41.56%

Asset Class

Equity

ETF Category

Health Care

Assets

612.66M

PE Ratio

22.52

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	7.31%	186,808
2	GILD	Gilead Sciences, Inc.	7.21%	486,829
3	VRTX	Vertex Pharmaceuticals Incorporated	7.14%	145,959
4	REGN	Regeneron Pharmaceuticals, Inc.	6.25%	73,203
5	ALNY	Alnylam Pharmaceuticals, Inc.	3.24%	93,457
6	INSM	Insmed Incorporated	2.33%	151,934
7	BIIB	Biogen Inc.	2.17%	103,462
8	RVMD	Revolution Medicines, Inc.	2.15%	139,704
9	UTHR	United Therapeutics Corporation	1.99%	30,923
10	ARGX	argenx SE	1.77%	19,950
11	RPRX	Royalty Pharma plc	1.70%	302,264
12	MRNA	Moderna, Inc.	1.61%	278,639
13	ROIV	Roivant Sciences Ltd.	1.57%	503,456
14	ILMN	Illumina, Inc.	1.57%	107,902
15	INCY	Incyte Corporation	1.51%	140,454
16	SMMT	Summit Therapeutics Inc.	1.37%	547,234
17	VTRS	Viatris Inc.	1.35%	812,957
18	BBIO	BridgeBio Pharma, Inc.	1.14%	136,657
19	n/a	Ascendis Pharma	1.13%	43,297
20	NBIX	Neurocrine Biosciences, Inc.	1.02%	70,606
21	IONS	Ionis Pharmaceuticals, Inc.	0.97%	116,187
22	JAZZ	Jazz Pharmaceuticals plc	0.97%	43,232
23	BNTX	BioNTech SE	0.96%	80,181
24	MDGL	Madrigal Pharmaceuticals, Inc.	0.94%	16,148
25	EXEL	Exelixis, Inc.	0.93%	182,679

Showing 25 of 266 holdings

Subscribe to see the full list

Activate Now

As of Apr 24, 2026